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ABSTRACT 
Objective: a) To estimate the ideal percentage of polymer (methyl cellulose) and the drug (simvastatin) for controlled release gel. b) To evaluate 
the release kinetics and physical property. 
Methods: Drug polymer interaction was studied using Differential Scanning Calorimeter (DCS) and Fourier Transform Infrared Spectroscopy 
(FTIR). Simvastatin powder was hydrolysed to active simvastatin hydroxyl acid. Nine gel formulations using three different concentrations of 
simvastatin (SMV) (1.2%, 1.7% and 2.2%) and three concentration of methyl cellulose (MC) (4%, 5% and 6%) were prepared. Drug release kinetics 
of 9 formulations was assessed using open end tube method with the dialysis membrane. The physical property was studied using rheometer. 
Results: DSC and FITR results showed no drug polymer interaction. The release kinetics of all nine formulations was in a controlled manner. 4% MC 
2.2% SMV, 5% MC 2.2% SMV, 6% MC 2.2% SMV showed controlled drug release compared to other six formulations. The pH of all the nine 
formulations ranged between 6.21–6.25. The drug content of each formulation was above 97.9%. 
Conclusion: This study showed that increase in polymer concentration in the gel increased the controlled release of the drug and addition of the 
drug to the gel decreased the viscosity of the gel. 
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INTRODUCTION 
Gingival epithelium acts as a physical barrier to oral microorganisms 
[1] and it is constantly moistened by saliva. Oral cavity harbours 
unique microbial flora; an interaction between the host and the 
bacteria causes epithelial destruction leading to inflammatory 
periodontal diseases. Local drug delivery of antimicrobial agents [2], 
non steroidal anti-inflammatory agents (NSAIDS) [3] and anaesthetics 
[4] by means of topical application and sub-gingival [5] route is a non 
invasive treatment option employed in the treatment of oral diseases 
and conditions. Statins are specific competitive inhibitors of 3-hydroxy 
2-methyl-glutaryl coenzyme A (HMGCoA) reductase originally used to 
lower cholesterol level [6]. The anti-inflammatory action [7] of statins 
permits its use to treat various inflammatory conditions other than 
hyper lipedimia. The anti inflammatory [8] and bone regenerative 
properties [8] of statins could aid in the treatment of inflammatory 
periodontal diseases and subsequently aid in bone regeneration. In a 
clinical scenario, in order to achieve the anti inflammatory and bone 
regenerative property of the drug, it has to be released in a controlled 
manner to the specific site. Various polymers have been used in local 
drug delivery systems depending on its interaction with the drug. 
Local drug delivery agents can be used in various forms like gels and 
microspheres [9]. Vehicles such as lactide/glycolide polymer, 
hydroxypropyl methyl cellulose and carbopol have been used in 
various studies [9-11]. Hydroxypropyl methylcellulose (HPMC) has 
been widely studied for their applications in oral sustained release 
(SR) systems. The rate of drug release from HPMC matrix is dependent 
on various factors such as type of polymer/drug, polymer/drug ratio, 
particle size of drug/polymer and the type and amount of fillers used 
in the formulation [12]. Previous studies have used 4% HPMC polymer 
and either 1.2% simvastatin (SMV) [8] or 2.2% SMV [13] drug for gel 
formulation. Till date, the physical properties, drug release kinetics 
and ideal concentration of HPMC and SMV for gel formulation have not 
been evaluated in vitro. Hence this study was undertaken to estimate 
the ideal percentage of polymer (methyl cellulose) and the drug 
(simvastatin) which can release adequate amount of drug over a time 
period to produce the desired effect. 
MATERIALS AND METHODS 
Commercially available methyl cellulose 4000cps (MC) powder 
(Central drug house, New Delhi) and simvastatin powder (SMV) 
(Microlabs, Mumbai) were procured. Preformulation studies to 
assess the interaction between simvastatin and methyl cellulose was 
performed prior to gel formulation. 
Differential scanning calorimetry (DSC) 
Thermal characterization of SMV, MC and mixture of MC/SMV was 
performed with differential scanning calorimeter. All the samples were 
weighed individually (2.00±0.5 mg) and placed in sealed aluminium 
pans and scanned at a temperature 20 °C/min from 25 °C to 300 °C. 
Hydrolysis of simvastatin 
Simvastatin powder was converted to the active simvastatin 
hydroxyl acid by dissolving weighed amount of simvastatin powder 
in 95% ethanol, 0.1M sodium hydroxide (NaOH) and heated at 50o
Preparation of methyl cellulose gel 
C 
for two hours and then the pH was adjusted to 7.4 by adding 0.1M 
hydrochloric acid (HCl) and stored at-20 °C [14]. 
Nine formulations of methyl cellulose simvastatin gel were prepared 
(table 1). 4% methyl cellulose gel was prepared by dispersing 2 gm of 
methyl cellulose powder in 50 ml of distilled water with continuous 
stirring, 5% methyl cellulose was prepared by dispersing 2.5 gm of 
methyl cellulose and 6% methyl cellulose gel was prepared by dispersing 
3 gm of methyl cellulose powder in 50 ml of distilled water respectively. 
Three concentrations of SMV 1.2%, 1.7% and 2.2% were previously 
added to distilled water with continuous stirring. The prepared gel was 
stirred well in a mechanical stirrer to get a homogenous mix.  
 
Table 1: Formulations of methylcellulose gel and codes 
Formulation code Methyl cellulose (%) Simvastatin (%) 
F1 4 1.2 
F2 4 1.7 
F3 4 2.2 
F4 5 1.2 
F5 5 1.7 
F6 5 2.2 
F7 6 1.2 
F8 6 1.7 
F9 6 2.2 
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Development of method to estimate simvastatin 
The solutions of SMV were prepared separately in methanol at a 
concentration of 6μg/ml. It was scanned in the wavelength range of 
200-400 nm. Data were recorded at an interval of 1 nm. The spectra 
of the drug was drawn to obtain the over line spectra. The 
wavelength selected for SMV analysis was 236 nm. 
Construction of calibration curve 
Standard stock solutions were prepared by dissolving 100 mg of the 
drug samples in 100 ml volumetric flask separately and the volume 
was made up with methanol to get a concentration of 1 mg/ml. From 
this, suitable dilutions were made in methanol to get the working 
standard solutions of 4-16μg/ml for SMV. The absorbance values at 
236 nm were determined for different concentration range 4-
16mcg/ml for working standards (fig. 1) [15]. 
 
 
Fig. 1: Calibration curve of simvastatin 
Sample size n=3. Values expressed as mean±SEM 
 
Analysis of in vitro release profile of the drug 
Open end tube 
The donor compartment of the open end tube was a cylindrical glass 
tube sealed at the one end with a single layer of dialysis membrane, 1 mg 
of gel was taken in the open end tube and placed on the inner side over 
the dialysis membrane which was immersed to 1 cm depth into the 
beaker (receptor compartment) containing 50 ml of phosphate buffer 
saline (PBS) ph 7.4. A magnetic bead was suspended at the bottom of the 
receptor compartment. The temperature was maintained at 37±1 °C 
throughout the study. Magnetic stirrer is used to for continuous stirring 
of the buffer in the receptor compartment and to maintain a constant 
temperature. Aliquots of 3 ml were withdrawn periodically at intervals 
of 15 min up to 312 h and was replaced with 3 ml of fresh PBS which was 
pre heated to 37±1 °C. The amount of drug release was estimated using 
UVspectrophotometer at 236 nm. 
UV spectrometer analysis 
The U-V spectrometer was set to 236 nm and both the cuvettes were 
filled with PBS of pH 7.4 and absorbance were checked. Keeping one 
cuvette with PBS as control the other cuvette was loaded with 
sample and absorbance was noted at 236 nm. the same method was 
repeated for all the samples. 
Estimation of drug content in the formulated gel 
1 mg of the gel was dissolved in 10 ml of PBS in a volumetric flask 
and filtered. Absorbance values were measured at respective ƛ max 
(236 nm) using UV spectrometer. Concentrations of drug were 
calculated from the standard calibration curve. 
Surface pH of the gel 
An acidic or alkaline formulation is bound to cause irritation on the 
mucosal membrane and hence this parameter assumes significance 
while developing a mucoadhesive formulation. The surface pH was 
determined by using a digital glass electrode pH meter. pH was 
noted by bringing the electrode near the surface of the formulations 
and allowing it to equilibrate for one minute. 
Viscosity of the gel 
The viscosity of the 4%, 5%, 6% methyl cellulose gel without SMV 
and 6% methyl cellulose gel with 2.2% SMV were estimated using 
rheometer. The diameter of rheometer plate and interplate were 
20.05 mm and 0.052 mm respectively; whereas the cone angle was 1 
°. The shear stress value was increased automatically by the 
instrument to a maximum value of 1000 Pascal (Pa) over a time 
period of 20 seconds.  
Stability studies 
The selected final formulation (F9) was subjected to a stability 
testing for six months as per the International Conference on 
Harmonisation 
In thermal characteristic study, it was observed that the melting 
point of methyl cellulose started at 65.7
(ICH) norms at a temperature of 40ºC ± 2°C. At 
various time intervals drug content and pH were analysed [16]. 
RESULTS 
Fourier transform infrared spectroscopy (FTIR) 
FTIR analysis revealed that the functional groups of the methyl 
cellulose and simvastatin remained unaltered when the analysis was 
carried out individually for simvastatin and methyl cellulose as well 
as when simvastatin and methylcellulose were mixed and assessed.  
DSC 
oC and the peak occurred 
between 105oC to 110oC (fig. 2a). The melting point of simvastatin 
started at 132oC and the peak occurred between 140oC to 145o
 
C (fig. 
2b). When simvastatin and the methyl cellulose were mixed and 
scanned, the peaks of simvastatin and methyl cellulose remained 
unchanged (fig. 2c).  
 
Fig. 2: Thermal analysis of methylcellulose and simvastatin-2a: Methyl cellulose, 2b: Simvastatin, 2c: Methyl cellulose and simvastatin 
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In vitro drug release 
The drug release profile of each formulation showed that all nine 
formulations demonstrated a controlled release. 2.2% SMV with 4%, 
5%, 6% MC gel (F3, F6, F9) showed a longer duration of controlled 
release compared to other formulations. The drug release of all the 
formulations are shown in fig. 3 (fig. 3a, 3b, 3c, 3d). 
Drug content, pH and appearance 
The pH of all the formulations was between 6.22±0.014 and the drug 
content varied from 97.9±0.1 in formulation F1 to 99.9±0.06 in 
formulation F9. But the appearance of all the formulations was clear 
(table 2). 
Viscosity 
The viscosity of 4% methylcellulose gel without simvastatin (P1) 
was 28.58 Pa·s which increased to 87.35 Pa·s for 6% methyl 
cellulose gel without simvastatin (P3). When the simvastatin was 
added to 6% methylcellulose gel the viscosity decreased to 85.35 
Pa·s
Viscosity in relation to shear 
. (table 3) 
When the shear rate was increased from 0 to 10,000 for all the four 
formulations 4%, 5%, 6% methyl cellulose gel without simvastatin 
and for 6% methyl cellulose gel with 2.2% simvastatin the viscosity 
increased from 0 to 85 Pa·s
 
 for all the formulations (fig. 4). 
 
Fig. 3: In vitro drug release profile 
Sample size n=3. Values expressed as mean±SEM. X axis represents percentage of drug released and y axis represents time in h 
 
Table 2: Drug content in the 1 gm of each formulation 
Formulation code pH Drug content (%) Appearance 
F1 6.22±0.0153 97.9±0.1 Clear 
F2 6.21±0.0173 98.9±0.5 Clear 
F3 6.25±0.0379 99.2±0.85 Clear 
F4 6.21±0.0400 98.1±0.95 Clear 
F5 6.22±0.0400 98.3±0.55 Clear 
F6 6.22±0.0802 99.2±0.35 Clear 
F7 6.20±0.0321 98.2±0.6 Clear 
F8 6.22±0.0252 99.4±0.5 Clear 
F9 6.23±0.0611 99.9±0.06 Clear 
Values are expressed as mean±SD (standard deviation), sample size n=3 
 
 
Fig. 4: Viscosity of the gel formulations in relation to shear 
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Table 3: Viscosity of the selected gel formulation 
S. No. Methyl cellulose Simvastatin Viscosity[Pa. s]* code 
1 4% - 28.58±1.02 P1 
2 5% - 42.42±0.53 P2 
3 6% - 87.35±1.35 P3 
6 6% 2.2% 85.32±1.24 F9 
Values are expressed as mean±SD (standard deviation), sample size n=3, *Pa·s = 
 
Pascal-second 
Table 4: Physical property of the selected F9 formulation 
Formulation code Duration (months) pH Drug content (%) Appearance 
F9 0 6.23±0.0611 99.9±0.06 Clear 
1 6.23±0.0404 98.3±0.56 Clear 
2 6.24±0.0351 98.1±0.96 Clear 
3 6.27±0.0200 97.6±0.36 Clear 
6 6.25±0.0100 97.1±0.26 Clear 
Values are expressed as mean±SD (standard deviation), sample size n=3, F9 = MC 6% and SMV 2.2%. 
 
Stability 
The stability of the methyl cellulose gel for the formulation F9 was 
assessed at 1, 2, 3 and 6 mo post formulation. The drug content was 
99.9±0.06% at base line and 97.1±0.26 % after 6 mo. No change was 
observed in the pH due to storage; however change in the drug 
content was elicited as storage time increased. The appearance of 
the gel remained clear throughout the observation period (table 4). 
DISCUSSION 
For a drug to exert its property, effectively it must be delivered to the 
site along with an appropriate carrier at an adequate concentration 
and the drug must be able to leach out from the carrier into the 
surrounding milieu, for a considerable period of time. Thus, ideal 
concentration of both the drug and the carrier medium must be 
developed [14]. Compared the efficiency of simvastatin released from 
a sustained and intermittent released device and reported that 
simvastatin released from both the devices were effective in bone 
formation but intermittent release device showed better efficacy using 
cellulose acetate phthalate and pluronic F-127 as carrier medium. In 
this study, a total of nine groups were compared in order to determine 
the ideal combination of the carrier and drug which could release the 
active form of drug in a controlled release manner over time.  
The percentage of drug release from the three different 
concentrations of the carrier medium, each having three different 
drug concentrations was compared in this study. Previous studies 
had utilised 1.2% SMV and 2.2% SMV for human and animal model 
respectively. In the present study, an intermediate concentration 
(1.7% SMV) was included to evaluate if the desired therapeutic drug 
release could be achieved. Hence, we have taken three 
concentrations (1.2%, 1.7% 2.2%) of simvastatin and incorporated 
into three concentrations of a carrier agent, methyl cellulose (4% 
5%and 6%). Methylcellulose (MC) has been used extensively as a 
drug vehicle for various pharmaceutical applications and is generally 
considered as safe by the Food and Drug Administration. It is a 
promising biocompatible injectable scaffold for the repair of defects 
in the brain, nerve gap injuries and spinal cord injuries. Although 
methylcellulose gel is not readily metabolized in vivo, it does swell 
and erode as time goes by and the in vitro and in vivo results prove 
the safety of methylcellulose when placed or given to humans. FTIR 
spectroscopy result revealed that there is no interaction between MC 
and SMV as all the functional groups of SMV and MC remained 
unchanged when they were assessed as a mixture. Similarly, the 
thermal characteristics of MC and SMV were analysed by DSC and the 
peaks for MC and SMV remained constant in the mixture. This implies 
that no interaction had occurred between drug and the polymer when 
exposed to high temperature. Hence the FTIR and DSC proved that 
there is no alteration in the individual property of the MC and SMV and 
they MC is one of the appropriate polymer for SMV. 
The drug release from all the nine formulations demonstrated a 
sustained release. As the concentration of the polymer increased the 
sustained release of the drug prolonged (fig. 3). The three gel 
formulations with 4% methyl cellulose (F1,F2,F3) showed a 
sustained release (fig. 3a); the F3 formulation with 2.2% SMV 
reached the peak of 93% drug release in 288 h and exhibited a 
decline thereafter, whereas the other two formulations F1 and F2 
showed 87% and 90% drug release respectively. In 5% methyl 
cellulose formulations (F4, F5, F6) the maximum drug release 
percentage was observed in F6 formulation compared to F5 and F4 
after 288 h. In 6% methyl cellulose formulations (F7, F8, F9) the 
peak drug release of 98% was achieved in F9 after 288 h whereas in 
F8 the peak release of 90% was achieved after 312 h and in F7 
formulation 87% in 312 h. 
It was hypothesized that the initial concentration of the drug is 
directly proportional to the peak cumulative percentage of the drug 
release. Drug release was observed to be increased in all the three 
polymer concentration (4%, 5%, 6%). 2.2% SMV had sustained release 
for more period and reached the peak drug release of 90%. Hence 
2.2% of the drug concentration with 4%, 5% and 6% methyl cellulose 
were compared. At 288 h the peak drug release of 93% for 4% MC, 
90% for 5% MC and 98% for 6%MC were achieved. This indicated that 
if the polymer concentration is higher, then the cumulative drug 
release decreases every hour and increases the duration of release. 
The surface pHs of all the simvastatin gels was 6.22±0.014. pH of the 
simvastatin gel did not become acidic after addition of simvastatin in 
the form of simvastatin hydroxyl acid. This could possibly be due to 
neutralization of the acid to pH 7.4 before incorporating into the gel 
which makes it safe for intraoral topical application. 
The viscosity of the 4%, 5% and 6% methyl cellulose gels (P1, P2, P3) 
without simvastatin were 28.58±1.02Pa·s, 42.42±0.53Pa·s and 
87.35±1.35Pa·s respectively (table 3). It shows that the viscosity 
increased as the concentration of the polymer increased. After 
addition of SMV in 6% methyl cellulose gel, the viscosity of 6% MC gel 
without the drug decreased to 85.32±1.24Pa·s from 87.35±1.35Pa·s.
This could be attributed to the fact that the drug was added in a liquid 
form and the presence of alcohol in simvastatin which was initially 
used to convert the simvastatin powder to the active form. Hence, the 
liquid form of the drug had decreased the viscosity and increased 
the flowability of the F9 formulation compared to P3 formulation. 
The drug content in 1 gm of the gel in each formulation (F1 to F9) 
varied depending upon the polymer and drug concentration (table 
2). But the drug content in one gram of the each formulation showed 
that there was a homogenous distribution of the drug in each 
formulation. The ph remained the same in all the nine formulations 
which showed that increase in the drug or polymer concentration 
did not affect the ph of the formulations.  
  
As the shear stress increased gradually on the rheometer, the 
viscosity also increased gradually in all the four groups (P1, P2, P3 
and F9). This showed that addition of simvastatin did not affect the 
viscosity in relation to sheer (fig. 4). 
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The F9 formulation was stored for a period of six months the drug 
content, pH and appearance was assessed at baseline, 1 2, 3 and 6 
mo after formulation. The drug content was decreased from 
99.9±0.06% at base line to 97.1±0.26% after 6 mo (table 4). This 
shows that there was a loss of drug content as the storage period 
increased. Furthermore, the pH and the appearance of the gel were 
not affected due to storage.  
CONCLUSION 
6% methyl cellulose with 2.2% simvastatin gel (F9 formulation) 
showed prolonged controlled release. Increase in the concentration 
of the drug resulted in achieving a controlled release for a longer 
duration. In the present in vitro condition simvastatin followed zero 
order kinetics pattern of drug release. Further studies on the 
formulation of an in situ gel for oral application could extend the use 
of this gel to treat periodontal diseases. However, the anti 
inflammatory and anti microbial properties need to be evaluated in 
vivo to optimise the ideal therapeutic concentration. 
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